Therefore, in human hepatocellular carcinoma, PD-L1+MDSCs play important roles in the suppression of T cell function and tumor growth, and it is suggested that anti PD-L1 antibody treatment could be effective for hepatocellular carcinoma. This evidence concerns the gene CD274 and hepatocellular carcinoma.